LANTERN PHARMA INC (LTRN) Stock Cash Flow
NASDAQ:LTRN - Nasdaq - US51654W1018 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.88M | -20.78M | -15.96M | -14.26M | -12.36M | |||
| Depreciation Amortization | 17.80K | 17.30K | 14.60K | 10.00K | 10.00K | |||
| Change In Working Capital | 166.50K | 2.23M | 538.00K | -610.00K | 600.00K | |||
| Other non cash items | 572.70K | 722.60K | 1.06M | 2.09M | 1.16M | |||
| OPERATING CASH FLOW | -19.12M | -17.81M | -14.35M | -12.77M | -10.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -11.60K | -12.60K | -18.70K | -30.00K | -20.00K | |||
| Other Investing Activity | 7.18M | 3.38M | -911.50K | 210.00K | -19.52M | |||
| INVESTING CASH FLOW | 7.16M | 3.37M | -930.20K | 180.00K | -19.53M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | N/A | 66.70K | -500.00K | -2.18M | 68.20M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -4.78M | |||
| FINANCING CASH FLOW | 12.00K | 66.70K | -500.00K | -2.18M | 63.42M | |||
| Exchange Rate Effect | -36.90K | -49.50K | -28.50K | -10.00K | 0.00 | |||
| CHANGE IN CASH | -11.98M | -14.43M | -15.81M | -14.78M | 33.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.12M | -17.81M | -14.35M | -12.77M | -10.59M | |||
| Capital Expenditure | -11.60K | -12.60K | -18.70K | -30.00K | -20.00K | |||
| FREE CASH FLOW | -19.13M | -17.83M | -14.37M | -12.80M | -10.61M | |||
All data in USD